NewJour Home |
NewJour: V |
Search
[Prev] [Next]
Vaccine
-
Sender: owner-newjour@ccat.sas.upenn.edu
Subject: Vaccine
Date: Mon, 3 May 1999 11:31:03 -0400 (EDT)
Vaccine
http://www.elsevier.com/locate/vaccine
Content available to subscribers at:
http://www.sciencedirect.com/science/journal/0264410X
ISSN: 0264-410X
VACCINE is the pre-eminent journal for those interested in vaccines and
vaccination. It serves as an interface between academics, those in
research and developmet, and workers in the field. Relevant topics range
from basic research through to applications, safety and legislation.
Key aspects include:
human
veterinary
disease prevention
physiological manipulation
molecular biology
synthetic peptides
recombinant antigens
vectors
new immunogens
adjuvants
animal models
immunity
immunology of protection
fertility
academic research
developmental applications
field trials
clinical trials
laboratory productions
industrial production
social implications
epidemiology
efficacy
safety
legislation
regulation
cost/benefit
These aspects may be applied to diseases caused by:
viruses
bacteria
mycoplasma
protozoa
fungi
helminths
arthropods
prions
Audience
Research workers, product developers, clinicians and practitioners with
interests in virology, bacteriology, parasitology, mycology, immunology,
genetics, biotechnology and biochemistry in the medical and veterinary
fields.
Contact:
usinfo-f@elsevier.com
NewJour Home |
NewJour: V |
Search
[Prev] [Next]